Lung vascular injury.
Newman
J H
JH
Department of Medicine, Vanderbilt University School of Medicine, Nashville.
D043925:Angiogenesis Inducing Agents / Q000502:physiology; D000818:Animals; D002199:Capillary Permeability; D007378:Interleukins / Q000502:physiology; D008214:Lymphocytes / Q000502:physiology; D008264:Macrophages / Q000502:physiology; D018129:Phosphatidylinositol Phosphates; D010716:Phosphatidylinositols / Q000502:physiology; D011453:Prostaglandins / Q000502:physiology; D011651:Pulmonary Artery / Q000293:injuries* / Q000503:physiopathology; D011667:Pulmonary Veins / Q000293:injuries* / Q000503:physiopathology; D013931:Thromboxanes / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology; D014655:Vascular Resistance
D043925:Angiogenesis Inducing Agents; D007378:Interleukins; D018129:Phosphatidylinositol Phosphates; D010716:Phosphatidylinositols; D011453:Prostaglandins; D013931:Thromboxanes; D014409:Tumor Necrosis Factor-alpha